Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 6,000 shares at $92.45 ($560K) on 2018-06-05, disclosed to the SEC on 2018-06-07.
Seasonal sale ($560k) by Chief Scientific Officer — this insider has traded AGIO in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.45 | 802 | $74K | 13.2% |
| 2 | $92.45 | 802 | $74K | 13.2% |
| 3 | $93.27 | 1,259 | $117K | 21.0% |
| 4 | $93.27 | 1,259 | $117K | 21.0% |
| 5 | $94.28 | 939 | $89K | 15.8% |
| 6 | $94.28 | 939 |
| $89K |
| 15.8% |
| Total | $93.37 avg | 6,000 | $560K | 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |